The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $109.30

Today's change+10.38 +10.49%
Updated April 26 4:01 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $109.30

Today's change+10.38 +10.49%
Updated April 26 4:01 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp Hits New 100-day High

Edwards Lifesciences Corp closed up sharply Wednesday, rallying (U.S.)$10.38 or 10.49% to (U.S.)$109.30 and setting a new 100-day high. Over the last five days, shares have gained 13.04% and 16.65% year to date. Shares have underperformed the S&P 500 by 13.72% during the last year.

Key company metrics

  • Open(U.S.) $109.12
  • Previous close(U.S.) $98.92
  • High(U.S.) $113.04
  • Low(U.S.) $106.74
  • Bid / Ask(U.S.) $106.90 / (U.S.) $109.30
  • YTD % change+16.65%
  • Volume7,668,116
  • Average volume (10-day)1,700,370
  • Average volume (1-month)1,616,021
  • Average volume (3-month)2,094,110
  • 52-week range(U.S.) $81.12 to (U.S.) $121.75
  • Beta0.66
  • Trailing P/E36.17×
  • P/E 1 year forward29.02×
  • Forward PEG1.81×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.02
Updated April 26 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.61%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue768739759697
Total other revenue--------
Total revenue768739759697
Gross profit555538557517
Total cost of revenue213201203180
Total operating expense567554590514
Selling / general / administrative234230229213
Research & development115113113102
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)574412
Other operating expenses, total1395
Operating income200185169183
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax200185169183
Income after tax159141127143
Income tax, total42444240
Net income159141127143
Total adjustments to net income--------
Net income before extra. items159141127143
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items159141127143
Inc. avail. to common incl. extra. items159141127143
Diluted net income159141127143
Dilution adjustment--0--0
Diluted weighted average shares218218217218
Diluted EPS excluding extraordinary itemsvalue per share0.730.650.580.66
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.740.670.730.70